Study looks at using the immune system to reduce prostate cancer risk

Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.

Read the whole article on Physorg

More from Physorg